IRWD vs RJF · P/E 5.7, rev $219.5M vs rev $15.91B
Ironwood Pharmaceuticals Inc (IRWD) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
RJF (RJF) common stock.
Latest reported IRWD revenue for 2026-06-30 was $219.5M. Net income was $92.1M. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
IRWD currently screens at market cap $579.4M and trailing P/E 5.7. RJF currently screens at market cap $0.
Not investment advice. Open the IRWD and RJF stock pages for the full models.
Not investment advice.